Cory Kasimov is a senior managing director and fundamental research analyst at Evercore ISI, leading coverage of mid- and small-cap biotech companies.
Mr. Kasimov’s two decades of research experience includes over 15 years as a senior biotech analyst at J.P. Morgan. His differentiated, actionable research product and educational events have led to consistent recognition in Institutional Investor’s All-America Research poll, where Mr. Kasimov most recently repeated a top 3 ranking in the large-cap biotech sector and regularly achieves runner-up status in the SMID biotech category.
Mr. Kasimov earned an MBA in finance and marketing from Tulane University’s A.B. Freeman School of Business and an MPH in health systems management from Tulane’s School of Public Health and Tropical Medicine. He also holds a B.S. in cellular and molecular biology from Tulane.